References
- Griffiths I D, Kane SP. Sulphasalazine-induced lupus syndrome in ulcerative colitis. Br Med J 1977; 1188–9
- Carr-Locke DL. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease. Am J Gastroenterol 1982; 77: 614–6
- Clementz G L, Dolin BJ. Sulfasalazine-induced lupus erythematosus. Am J Med 1988; 84: 535–8
- Deboever G, Devogelaere R, Holvoet G. Sulphasalazine-induced ulcerative colitis. Am J Gastroenterol 1989; 84: 85–6
- Wildhagen K, Hartung K, Hammer M, Mau W, Schmidt R E, Deicher H, et al. Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment. Clin Rheumatol 1993; 12: 265–7
- Walker E M, Carty JE. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis. Br J Rheumatol 1994; 33: 175–6
- Caulier M, Dromer C, Andrieu V, Le Guennec P, Fournie B. Sulfasalazine induced lupus in rheumatoid arthritis. J Rheumatol 1994; 21: 750–1
- Bray V J, West S G, Schultz K T, Boumpas D T, Rubin RL. Antihistone antibody profile in sulfasalazine induced lupus. J Rheumatol 1994; 21: 2157–8
- Laversuch C J, Collins D A, Charles P J, Bourke BE. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 1995; 34: 435–9
- Tan E M, Cohen A S, Fries J F, Masi A T, Mc Shane D J, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
- Dent M T, Ganapathy S, Holdsworth C D, Channer KC. Mesalazine induced lupus-like syndrome. BMJ 1992; 305: 159
- Lim A G, Hine KR. Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalazine. BMJ 1994; 308: 113
- Niessner M, Volk BA. Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101: 428–35
- Hagiwara E, Gourley M F, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 1996; 39: 379–85